Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Silver Spring, MD, USA
Due to extenuating circumstances, this meeting is postponed until further notice.
US Federal Drug Administration (FDA) is conducting its first public meeting on Patient-Focused Drug Development for Vitiligo.
The meeting is intended to allow FDA to obtain patient perspectives on the impact of vitiligo, including on daily life, patient views on treatment approaches, and decision factors taken into account when selecting a treatment.
You can participate in three ways:
- Register, attend the meeting and take active part in discussions.
- Join webcast and comment throughout the live stream.
- Submit your online comments before the meeting.
WHEN: Monday, March 30, 2020 at 1 p.m. to 5 p.m.
WHERE: FDA White Oak Campus 10903 New Hampshire Ave. Building 31, Great Room Silver Spring, MD 20903
- How long does it take to treat vitiligo?
Treatment results will vary by person and type of vitiligo. The rule of thumb is that you will need to allow at least 3 to 6 months before you begin to see results from any trea...
- Will it spread?
Vitiligo activity may vary considerably from person to person. In a good number of patients the disease goes on for 3-4 years and then it settles down, with one or two stubborn...
- What is vitiligo?
Vitiligo (pronounced vit-ill-EYE-go) is a relatively common skin disease characterized by smooth, white, painless spots or patches on various parts of the body and hairs above i...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.Copyright (C) Bodolóczki Júlia
By taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.